TGFB1 and neoplasm: Both the irradiated tumor cell-released microparticles and the combined therapy of PD-1 antibody with TGF-β inhibitor can turn M2-polarized TAMs into M1-TAMs to regulate the antitumor interactions between tumor cells and TAMs (85).